State Street’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $127M | Buy |
7,356,977
+562,275
| +8% | +$7.7M | ﹤0.01% | 1338 |
|
|
2026
Q1 | $84.5M | Buy |
6,794,702
+2,684,292
| +65% | +$36M | ﹤0.01% | 1470 |
|
|
2025
Q4 | $51.8M | Buy |
4,110,410
+136,662
| +3% | +$1.56M | ﹤0.01% | 1722 |
|
|
2025
Q3 | $39.8M | Buy |
3,973,748
+58,412
| +1% | +$524K | ﹤0.01% | 1848 |
|
|
2025
Q2 | $31.7M | Buy |
3,915,336
+224,982
| +6% | +$1.7M | ﹤0.01% | 1931 |
|
|
2025
Q1 | $30.9M | Sell |
3,690,354
-7,792
| -0.2% | -$65K | ﹤0.01% | 1890 |
|
|
2024
Q4 | $29.3M | Buy |
3,698,146
+183,425
| +5% | +$1.54M | ﹤0.01% | 2000 |
|
|
2024
Q3 | $29.2M | Buy |
3,514,721
+127,753
| +4% | +$999K | ﹤0.01% | 1994 |
|
|
2024
Q2 | $21.5M | Buy |
3,386,968
+442,770
| +15% | +$2.81M | ﹤0.01% | 2130 |
|
|
2024
Q1 | $17.8M | Buy |
2,944,198
+145,141
| +5% | +$818K | ﹤0.01% | 2245 |
|
|
2023
Q4 | $17M | Buy |
2,799,057
+463,947
| +20% | +$2.07M | ﹤0.01% | 2291 |
|
|
2023
Q3 | $9.85M | Buy |
2,335,110
+104,373
| +5% | +$389K | ﹤0.01% | 2605 |
|
|
2023
Q2 | $6.92M | Buy |
2,230,737
+100,768
| +5% | +$215K | ﹤0.01% | 2837 |
|
|
2023
Q1 | $2.96M | Buy |
2,129,969
+35,648
| +2% | +$71K | ﹤0.01% | 3190 |
|
|
2022
Q4 | $4.17M | Sell |
2,094,321
-37,818
| -2% | -$84.8K | ﹤0.01% | 3111 |
|
|
2022
Q3 | $4.31M | Sell |
2,132,139
-476,223
| -18% | -$1.33M | ﹤0.01% | 3139 |
|
|
2022
Q2 | $8.29M | Buy |
2,608,362
+161,817
| +7% | +$586K | ﹤0.01% | 2836 |
|
|
2022
Q1 | $10.2M | Sell |
2,446,545
-39,808
| -2% | -$176K | ﹤0.01% | 2813 |
|
|
2021
Q4 | $11.9M | Sell |
2,486,353
-43,444
| -2% | -$217K | ﹤0.01% | 2820 |
|
|
2021
Q3 | $13.5M | Sell |
2,529,797
-209,018
| -8% | -$1.05M | ﹤0.01% | 2705 |
|
|
2021
Q2 | $14M | Buy |
2,738,815
+303,813
| +12% | +$1.73M | ﹤0.01% | 2713 |
|
|
2021
Q1 | $16.4M | Sell |
2,435,002
-200,268
| -8% | -$1.11M | ﹤0.01% | 2482 |
|
|
2020
Q4 | $12M | Buy |
2,635,270
+142,237
| +6% | +$630K | ﹤0.01% | 2523 |
|
|
2020
Q3 | $9.67M | Sell |
2,493,033
-282,898
| -10% | -$1.21M | ﹤0.01% | 2451 |
|
|
2020
Q2 | $13.2M | Buy |
2,775,931
+358,789
| +15% | +$1.48M | ﹤0.01% | 2264 |
|
|
2020
Q1 | $8.41M | Buy |
2,417,142
+146,620
| +6% | +$621K | ﹤0.01% | 2378 |
|
|
2019
Q4 | $10.9M | Buy |
2,270,522
+424,083
| +23% | +$1.47M | ﹤0.01% | 2478 |
|
|
2019
Q3 | $5.36M | Sell |
1,846,439
-284,408
| -13% | -$992K | ﹤0.01% | 2752 |
|
|
2019
Q2 | $15.3M | Buy |
2,130,847
+190,355
| +10% | +$1.95M | ﹤0.01% | 2271 |
|
|
2019
Q1 | $27.5M | Sell |
1,940,492
-98,901
| -5% | -$1.31M | ﹤0.01% | 1838 |
|
|
2018
Q4 | $27.6M | Sell |
2,039,393
-25,317
| -1% | -$456K | ﹤0.01% | 1760 |
|
|
2018
Q3 | $45.8M | Buy |
2,064,710
+186,737
| +10% | +$3.93M | ﹤0.01% | 1585 |
|
|
2018
Q2 | $30.8M | Buy |
+1,877,973
| New | +$33M | ﹤0.01% | 1835 |
|
Other funds holding AMRX
TGA
RCMNY
State Street's AMRX Position: Q2 2026 in Review
State Street increased its Amneal Pharmaceuticals (AMRX) stake by 8.3% in Q2 2026, buying an estimated $7.7M and bringing the position to 7,356,977 shares worth $127M. The position accounts for ﹤0.01% of the portfolio, ranked #1338.
State Street first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- State Street held 7,356,977 shares of Amneal Pharmaceuticals worth $127M as of Q2 2026.
- State Street bought 562,275 Amneal Pharmaceuticals shares in Q2 2026, an estimated $7.7M.
- Amneal Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1338 holding.
- State Street first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.